Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 18;15(10):2488.
doi: 10.3390/pharmaceutics15102488.

Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy-Update 2022: Systematic Review

Pedro Amariles  1   2 , Mónica Rivera-Cadavid  1 , Mauricio Ceballos  1   3
Affiliations
Review

Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy-Update 2022: Systematic Review

Pedro Amariles et al. Pharmaceutics. .

Abstract

Background: The clinical outcomes of antiretroviral drugs may be modified through drug interactions; thus, it is important to update the drug interactions in people living with HIV (PLHIV).

Aim: To update clinically relevant drug interactions in PLHIV on antiretroviral therapy with novel drug interactions published from 2017 to 2022.

Methods: A systematic review in Medline/PubMed database from July 2017 to December 2022 using the Mesh terms antiretroviral agents and drug interactions or herb-drug interactions or food-drug interactions. Publications with drug interactions in humans, in English or Spanish, and with full-text access were retrieved. The clinical relevance of drug interactions was grouped into five levels according to the gravity and probability of occurrence.

Results: A total of 366 articles were identified, with 219 (including 87 citation lists) were included, which allowed for the identification of 471 drug interaction pairs; among them, 291 were systematically reported for the first time. In total 42 (14.4%) and 137 (47.1%) were level one and two, respectively, and 233 (80.1%) pairs were explained with the pharmacokinetic mechanism. Among these 291 pairs, protease inhibitors (PIs) and ritonavir/cobicistat-boosted PIs, as well as integrase strand transfer inhibitors (InSTIs), with 70 (24.1%) and 65 (22.3%) drug interaction pairs of levels one and two, respectively, were more frequent.

Conclusions: In PLHIV on antiretroviral therapy, we identify 291 drug interaction pairs systematically reported for the first time, with 179 (61.5%) being assessed as clinically relevant (levels one and two). The pharmacokinetic mechanism was the most frequently identified. PIs, ritonavir/cobicistat-boosted PIs, and InSTIs were the antiretroviral groups with the highest number of clinically relevant drug interaction pairs (levels one and two).

Keywords: HIV/AIDS; antiretroviral agents; drug interactions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred reporting items for systematic review and meta-analysis (PRISMA) [12] flow diagram for the systematic review of the clinical relevance of drug interactions in people living with human immunodeficiency virus.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization (WHO) HIV and AIDS, July of 2023. [(accessed on 5 September 2023)]. Available online: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
    1. Gandhi R.T., Bedimo R., Hoy J.F., Landovitz R.J., Smith D.M., Eaton E.F., Lehmann C., Springer S.A., Sax P.E., Thompson M.A., et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2023;329:63–84. doi: 10.1001/jama.2022.22246. - DOI - PubMed
    1. Amariles P., Giraldo N.A., Faus M.J. Interacciones medicamentosas: Aproximación para establecer y evaluar su relevancia clínica. Med. Clin. 2007;129:27–35. doi: 10.1157/13106681. - DOI - PubMed
    1. Amariles P., Madrigal-Cadavid J., Giraldo N.A. Clinical relevance of drug interactions: Proposal to update the classification based on the severity and probability of its occurrence. Rev. Chil. Infectol. 2021;38:304–305. doi: 10.4067/S0716-10182021000200304. - DOI - PubMed
    1. Amariles P., Giraldo N.A., Faus M.J. Interacciones medicamentosas en pacientes infectados con el VIH: Aproximación para establecer y evaluar su relevancia clínica. Farm Hosp. 2007;31:283–302. doi: 10.1016/S1130-6343(07)75392-8. - DOI - PubMed

LinkOut - more resources